Having been through two bouts of breast cancer, I am happy to be on this planet with my family, friends and neighbors.

The FDA granted orphan drug designation to ligufalimab for AML, reflecting its potential as an immune-based therapy that may ...

Bob Lane, a prostate cancer survivor and patient receiving Erleada (apalutamide), understands firsthand the challenges men face when discussing prostate cancer. In a previous interview with CURE, Lane ...

CURE connects oncology patients, survivors, and caregivers with expert guidance, cancer updates, treatment education, and ...

Dr. Prithviraj Bose discusses how patients with myelofibrosis can better understand their options and access the most up-to-date advancements in care.

The FDA has granted fast track designation to the investigational drug CRB-701 for recurrent or metastatic head and neck ...

Dr. Joshua K. Sabari sat down with Terri Conneran at the 2025 World Conference on Lung Cancer for a conversation on the importance of biomarker testing.

Since being diagnosed with breast cancer, my life has drastically changed. Time has helped each day become more precious and ...

Dr. Rosario Ligresti explained that while many GISTs are found incidentally, larger tumors may cause anemia, bleeding or ...

For patients with myelofibrosis, there is a risk of non-melanoma skin cancer or shingles among patients who received ...

The FDA granted breakthrough therapy designation to R-DXd for adults with CDH6-expressing platinum-resistant ovarian, ...

For men with prostate cancer, radical prostatectomy, or surgical removal of the prostate, isn’t guaranteed to be curative, as ...